Early Access — free while we kick the tires
EdgarHawk

Manning Meredith

Chief Commercial Officer

Officer
1 filing analyzed · 1 company · Latest 2025-03-31

Companies

Company Buys Sells Direction
SOLENO THERAPEUTICS INC SLNO 0 10 Net selling

Activity

March 2025
high
Sell
45,249 shares
$3,044,343
Significance 6/10

CCO Manning Meredith sells 45,249 shares (49.9% of holdings) for $3.0M at $67.28 blended average

Manning Meredith, Chief Commercial Officer, executed 9 separate sales on 2025-03-27 totaling 45,249 shares for $3,044,342.88, reducing his holdings from 90,600 shares to 45,351 shares. The transaction occurred near the 52-week high ($71.45 current price is -0.8% from the $71.99 peak), following a sharp 30-day rally of +46.4% and 90-day appreciation of +59.0%. The company reported negative net income of $-76,616,000.00 for its most recent fiscal year despite strong revenue growth of +138.8%, indicating continued unprofitability at scale. The disproportionate sale of roughly half his stake against a backdrop of recent price acceleration and ongoing losses warrants examination of whether this represents opportunistic liquidation during elevated valuations or a broader shift in the executive's position.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access